Policy | August 17, 2021
Centre allocates Rs 267.35 crores to Kerala for Covid response
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
'Unit-9' for manufacturing Gabapentin & other pharma (APIs) products is expected to be complete in Q3FY22
Idiopathic hypersomnia is a life-long condition, and the approval of Xywav will be instrumental in providing treatment for symptoms such as excessive sleepiness and difficulty waking, and in effectively managing this debilitating disorder
It strengthens Syngene’s portfolio as a fully integrated custom biomanufacturer with added mammalian and microbial capabilities for clinical and commercial supplies
The transaction improves patient experience, patient outcomes and aims to reduce health care costs
A treatment to prevent extreme symptoms and cut hospitalisation
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
Company working on COVID vaccine INO 4800
Deal signed with AOP Orphan for US commercial rights
The drug is indicated for mild and transient episodes of heart block
Subscribe To Our Newsletter & Stay Updated
